Bristol-Myers Squibb Postpones April 2, 2020 Investor Day

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) today announced that due to the ongoing COVID-19 pandemic, it will reschedule its planned April 2, 2020 Investor Day for a later date. The company will continue to assess the situation and follow guidance from local and global health authorities to determine the new date.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200323005105/en/

Bristol-Myers Squibb
Media:
[email protected]
609-252-3345

Investors:
Tim Power, 609-252-7509, [email protected]
Nina Goworek, 908-673-9711, [email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• Green Electricity Illuminates Indoor Ski Resort in Central China
• Pump.fun Price Prediction: Why Memecoin Traders Are Watching PUMP and MemeToro Ahead of the Next Crypto Pump
• Monero Price Prediction Eyes $500 as DEX Volume Hits $700M and Pepeto Presale Pulls In $10.7M